FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1290.22.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1290.22/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1290.22
Version20250925
Statusactive
Date2025-09-25T01:02:56-04:00
NameSCAHydroxyureaTreatment
TitleSCA hydroxyurea treatment
Realmus
Authorityhl7
DescriptionFor MCO reporting using admin data
Purpose(Clinical Focus: hydroxyurea treatment for sickle cell anemia Hb SS or Hb S beta zero thalassemia),(Data Element Scope: RxNorm codes for hydroxyurea treatment for sickle cell anemia),(Inclusion Criteria: RxNorm codes for hydroxyurea treatment),(Exclusion Criteria: none)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1290.22",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2025-09-25T01:02:56.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "IPRO Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-09-25"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2025-09-25"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1290.22",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1290.22"
    }
  ],
  "version": "20250925",
  "name": "SCAHydroxyureaTreatment",
  "title": "SCA hydroxyurea treatment",
  "status": "active",
  "date": "2025-09-25T01:02:56-04:00",
  "publisher": "IPRO Steward",
  "description": "For MCO reporting using admin data",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: hydroxyurea treatment for sickle cell anemia Hb SS or Hb S beta zero thalassemia),(Data Element Scope: RxNorm codes for hydroxyurea treatment for sickle cell anemia),(Inclusion Criteria: RxNorm codes for hydroxyurea treatment),(Exclusion Criteria: none)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "5552",
            "display": "hydroxyurea"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:80b6bd05-fe48-44d2-87c8-39827de2ed28",
    "timestamp": "2025-11-24T16:58:41-05:00",
    "total": 1,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09022025",
        "code": "5552",
        "display": "hydroxyurea"
      }
    ]
  }
}